High levels of stromal cell-derived factor-1α predict secondary cardiac events in stable patients with a history of myocardial infarction
- PMID: 27496337
- DOI: 10.1016/j.jjcc.2016.06.011
High levels of stromal cell-derived factor-1α predict secondary cardiac events in stable patients with a history of myocardial infarction
Abstract
Background: We recently showed that stromal cell-derived factor (SDF)-1α, a pro-inflammatory mediator, is produced in infarcted myocardium and is associated with left ventricular (LV) adverse remodeling and progressive dysfunction following acute myocardial infarction (AMI). The current study examined whether SDF-1α levels in the peripheral vein can provide prognostic information of outcomes in stable patients with a history of MI.
Methods: Plasma levels of SDF-1α in the peripheral vein were measured by enzyme-linked immunosorbent assay in 192 stable patients with a history of MI. All patients were followed prospectively for a period of 90 months or until occurrence of one of the following cardiac events: cardiac death, non-fatal myocardial infarction, unstable angina requiring unplanned coronary revascularization, or worsening heart failure requiring hospital admission.
Results: During the follow-up period (77±26 months), 30 patients had cardiac events. Multivariate Cox analysis revealed that high levels of SDF-1α (≥2162pg/mL; a cut-off value determined by receiver-operating characteristic analysis) were a significant predictor of cardiac events, independent of traditional risk factors (HR: 1.98; 95% CI: 1.38-2.85; p<0.001). The addition of high levels of SDF-1α to conventional risk factors including brain natriuretic peptide improved net reclassification improvement (NRI) and integrated discrimination improvement (IDI) (NRI 0.90, p<0.0001; and IDI 0.05, p=0.002).
Conclusions: High levels of SDF-1α predicted secondary cardiac events in stable patients with a history of MI. SDF-1α levels may be a useful risk assessment tool in patients with a history of MI.
Keywords: Cardiac events; Inflammatory marker; Myocardial infarction; Prognosis; Stromal cell-derived factor-1α.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Angiotensin II receptor blockers suppress the release of stromal cell-derived factor-1α from infarcted myocardium in patients with acute myocardial infarction.J Cardiol. 2018 Apr;71(4):367-374. doi: 10.1016/j.jjcc.2017.10.002. Epub 2017 Nov 10. J Cardiol. 2018. PMID: 29129394
-
High levels of stromal cell-derived factor-1α predict short-term progression of renal dysfunction in patients with coronary artery disease.Clin Exp Nephrol. 2019 Jul;23(7):920-927. doi: 10.1007/s10157-019-01722-9. Epub 2019 Mar 4. Clin Exp Nephrol. 2019. PMID: 30830550
-
Sustained myocardial production of stromal cell-derived factor-1α was associated with left ventricular adverse remodeling in patients with myocardial infarction.Am J Physiol Heart Circ Physiol. 2015 Nov 15;309(10):H1764-71. doi: 10.1152/ajpheart.00493.2015. Epub 2015 Sep 25. Am J Physiol Heart Circ Physiol. 2015. PMID: 26408542
-
Proenkephalin and prognosis after acute myocardial infarction.J Am Coll Cardiol. 2014 Jan 28;63(3):280-9. doi: 10.1016/j.jacc.2013.09.037. Epub 2013 Oct 16. J Am Coll Cardiol. 2014. PMID: 24140658
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
Cited by
-
A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies.PLoS One. 2017 Apr 5;12(4):e0174447. doi: 10.1371/journal.pone.0174447. eCollection 2017. PLoS One. 2017. PMID: 28379992 Free PMC article.
-
Stromal Cell-derived Factor-1 and CXC Chemokine Receptor Type-4 are Associated with Cardiovascular Disease in Patients under Hemodialysis.Int J Prev Med. 2019 Dec 10;10:219. doi: 10.4103/ijpvm.IJPVM_69_18. eCollection 2019. Int J Prev Med. 2019. PMID: 31929866 Free PMC article.
-
The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis.Front Cardiovasc Med. 2022 Jul 27;9:938540. doi: 10.3389/fcvm.2022.938540. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35966557 Free PMC article.
-
The expression and biological function of chemokine CXCL12 and receptor CXCR4/CXCR7 in placenta accreta spectrum disorders.J Cell Mol Med. 2020 Mar;24(5):3167-3182. doi: 10.1111/jcmm.14990. Epub 2020 Jan 28. J Cell Mol Med. 2020. PMID: 31991051 Free PMC article.
-
Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study.Life (Basel). 2021 May 1;11(5):414. doi: 10.3390/life11050414. Life (Basel). 2021. PMID: 34062730 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical